XML 65 R56.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Supplemental Balance Sheet Information Related to Operating and Financing Leases (Details) - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Lessee, Lease, Description [Line Items]    
Right-of-use assets, net [1] $ 3,499 $ 3,499
Machinery and equipment, net 2,021 2,088
Total financing lease liabilities 89  
Operating And Financing Leases [Member]    
Lessee, Lease, Description [Line Items]    
Right-of-use assets, net 1,957 2,463
Right-of-use lease liabilities, current 687 743
Right-of-use lease liabilities, noncurrent 2,550 3,237
Total operating lease liabilities 3,237 3,980
Machinery and equipment 537 537
Accumulated depreciation (473) (364)
Machinery and equipment, net 64 173
Current liabilities 89 107
Noncurrent liabilities 89
Total financing lease liabilities $ 89 $ 196
Weighted average remaining lease term, Operating lease 4 years 3 months 18 days 5 years 1 month 6 days
Weighted average remaining lease term, Financing lease 9 months 18 days 1 year 9 months 18 days
Operating lease 11.26% 11.19%
Financing lease 11.55% 11.55%
[1] Oncocyte recorded certain right-of-use assets and liabilities for operating leases in accordance with ASC 842 (see Note 10).